Drug Trial Radar · NCT06813781
Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004
Last checked: Nov 19, 2026Latest source record: Oct 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
33
Actual
Start
Dec 19, 2024
Primary completion
Oct 2, 2025
Study completion Oct 2, 2025
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- Fortrea Clinical Research Unit Inc.
- First posted
- Feb 7, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a Phase I, multicentre, single-dose, non-randomised, open-label, parallel-group study to examine the PK, safety, and tolerability of AZD5004 in male and female participants with mild, moderate, and severe hepatic impairment compared with participants with normal hepatic function.
Conditions
- Hepatic Impairment
Interventions
AZD5004Drug
Dose 1
Primary outcomes
What the sponsor says the trial is designed to measure.
- AUCinfTime frame: Day 1 to Day 6
- AUClastTime frame: Day 1 to Day 6
- CmaxTime frame: Day 1 to Day 6
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Lake Forest, California
Research Site
Rialto, California
Research Site
Miami Lakes, Florida
Research Site
Orlando, Florida
Research Site
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.